Revenues of Protagenic Therapeutics, Inc.\new from 30 Jun 2010 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Protagenic Therapeutics, Inc.\new quarterly and annual Revenues in USD history and change rate from 30 Jun 2010 to 30 Jun 2025.
  • Protagenic Therapeutics, Inc.\new Revenues for the quarter ending 30 Jun 2025 was $0.
  • Protagenic Therapeutics, Inc.\new Revenues for the twelve months ending 30 Jun 2025 was $0.
  • Protagenic Therapeutics, Inc.\new annual Revenues for 2024 was $0.
  • Protagenic Therapeutics, Inc.\new annual Revenues for 2023 was $0.
  • Protagenic Therapeutics, Inc.\new annual Revenues for 2022 was $0.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)

Protagenic Therapeutics, Inc.\new Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $0 $0 $0 01 Apr 2025 30 Jun 2025 10-QT 10 Sep 2025 2026 Q1
Q1 2025 $0 $0 $0 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $0 $0 $0 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $0 $0 $0 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $0 $0 $0 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $0 $0 $0 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $0 $0 $0 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $0 $0 $0 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $0 $0 $0 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $0 $0 $0 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $0 $0 01 Oct 2022 31 Dec 2022 10-K/A 14 May 2024 2023 FY
Q3 2022 $0 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $0 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $0 $0 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $0 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q3 2017 $0 $0 $0 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 $0 $0 $0 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 $0 $0 $0 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 $0 $0 01 Oct 2016 31 Dec 2016 10-K/A 08 May 2017 2016 FY
Q3 2016 $0 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3
Q2 2016 $0 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $0 $0 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q1 2015 $0 01 Jan 2015 31 Mar 2015 10-Q 25 Jul 2016 2016 Q1
Q3 2011 $12,326,000 +$3,149,000 +34% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 $6,270,000 -$4,543,000 -42% 01 Apr 2011 30 Jun 2011 10-Q/A 07 Sep 2011 2011 Q2
Q3 2010 $9,177,000 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011 2011 Q3
Q2 2010 $10,813,000 01 Apr 2010 30 Jun 2010 10-Q/A 07 Sep 2011 2011 Q2

Protagenic Therapeutics, Inc.\new Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $0 $0 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $0 $0 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $0 $0 01 Jan 2022 31 Dec 2022 10-K/A 14 May 2024 2023 FY
2021 $0 $0 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $0 01 Jan 2020 31 Dec 2020 10-K 07 Apr 2022 2021 FY
2016 $0 $0 01 Jan 2016 31 Dec 2016 10-K/A 08 May 2017 2016 FY
2015 $0 $0 01 Jan 2015 31 Dec 2015 10-K/A 08 May 2017 2016 FY
2014 $0 01 Jan 2014 31 Dec 2014 8-K/A 12 Jul 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.